Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma (Q38398311)

2 September 2017

title

Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma (English)

1 reference

2 September 2017

Yong Liu

1

1 reference

2 September 2017

Zhongwu Su

2

1 reference

2 September 2017

Guo Li

3

1 reference

2 September 2017

Changyun Yu

4

1 reference

2 September 2017

Shuling Ren

5

1 reference

2 September 2017

Donghai Huang

6

1 reference

2 September 2017

Songqing Fan

7

1 reference

2 September 2017

Yongquan Tian

8

1 reference

2 September 2017

Xin Zhang

9

1 reference

2 September 2017

Yuanzheng Qiu

10

1 reference

2 September 2017

language of work or name

English

0 references

publication date

7 March 2013

1 reference

International Journal of Cancer

2 September 2017

published in

1 reference

2 September 2017

volume

133

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

671-679

1 reference

2 September 2017

cites work

Global cancer statistics

1 reference

21 January 2018

Cancer statistics, 2010

1 reference

Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma

21 January 2018

1 reference

Metadherin, a cell surface protein in breast tumors that mediates lung metastasis

21 January 2018

1 reference

Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH.

21 January 2018

1 reference

Customized rapid subtraction hybridization (RaSH) gene microarrays identify overlapping expression changes in human fetal astrocytes resulting from human immunodeficiency virus-1 infection or tumor necrosis factor-alpha treatment

21 January 2018

1 reference

Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1

21 January 2018

1 reference

Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis

21 January 2018

1 reference

Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc

21 January 2018

1 reference

Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology

21 January 2018

1 reference

Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis

21 January 2018

1 reference

Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.

21 January 2018

1 reference

MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2.

21 January 2018

1 reference

Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma

21 January 2018

1 reference

Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival

21 January 2018

1 reference

Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity

21 January 2018

1 reference

Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion

21 January 2018

1 reference

Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis.

21 January 2018

1 reference

Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression

21 January 2018

1 reference

Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer

21 January 2018

1 reference

Epithelial-mesenchymal transition: implications in cancer progression and metastasis

21 January 2018

1 reference

Anti-angiogenesis therapy in cancer: current challenges and future perspectives

21 January 2018

1 reference

Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck.

21 January 2018

1 reference

Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance

21 January 2018

1 reference

Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma

21 January 2018

1 reference

Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.

21 January 2018

1 reference

Identification of genes conferring resistance to 5-fluorouracil

21 January 2018

1 reference

MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer

21 January 2018

1 reference

Astrocyte elevated gene-1 induces protective autophagy

21 January 2018

1 reference

Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition.

21 January 2018

1 reference

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition

21 January 2018

1 reference

Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model

21 January 2018

1 reference

Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.

21 January 2018

1 reference

Astrocyte elevated gene-1: far more than just a gene regulated in astrocytes.

21 January 2018

1 reference

Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1

21 January 2018

1 reference

LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals

21 January 2018

1 reference

Clinical proteomics and biomarker discovery.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28071

1 reference

2 September 2017

1 reference